Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
As expected, based on established risk factors for MS, a higher proportion of case participants had a history of smoking or a history of infectious mononucleosis compared to control participants, and the mean circulating concentration of 25(OH)D was lower in case participants than control participants.
Source: Results. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Case-control study.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
We used data from the Ausimmune Study, a large, multi-centre case: control study conducted in four latitudinally diverse regions of Australia.
Source: Abstract.
Participants aged 18 to 59 years were recruited from 2003 to 2006 as reported elsewhere [].
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Higher dietary choline and betaine intakes are associated with lower likelihood of central nervous system demyelination in Australian women
Case-control study · European Journal of Nutrition · 2026
Original publication title
Higher dietary choline and betaine intakes are associated with lower likelihood of central nervous system demyelination in Australian women
© The Author(s) 2026
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What objectives does the paper state?
Choline and betaine may be neuroprotective; however, the role of choline and betaine obtained from food in multiple sclerosis (MS) onset in humans is unclear. We aimed to test associations between intake of choline and betaine from food and likelihood of a first clinical diagnosis of central nervous system demyelination (FCD).
Source: PurposeAbstract: What methods does the paper describe?
We used data from the Ausimmune Study, a large, multi-centre case: control study conducted in four latitudinally diverse regions of Australia. Choline and betaine intakes were derived from food composition data sourced globally and dietary intake data collected using a self-administered, semiquantitative food frequency questionnaire. We used the alternate Mediterranean diet score (aMED) as a measure of diet quality. We applied logistic regression with full propensity score matching (264 cases, 474 controls) and stratified by sex (females: 205 cases/368 controls; males 59 cases/106 controls) to test associations between dietary choline and betaine intakes (per 50 mg/day) and likelihood of an FCD.
Models were adjusted for age, region, education, smoking history, history of infectious mononucleosis, deseasonalised serum 25-hydroxyvitamin D concentration, total energy intake, dietary misreporting and aMED, and bootstrapped (500 replicates).
Source: MethodsAbstract: Results
Independent of an overall healthy diet, higher choline intake (OR = 0.91; 95%CI 0.84 to 1.00; p = 0.05) and higher combined choline + betaine intake (OR = 0.92; 95%CI 0.86 to 0.99; p = 0.03) were significantly associated with lower likelihood of FCD in females only. We found no statistically significant associations in males (small sample).
Source: ResultsAbstract: Conclusion
Given the potential beneficial role of choline and betaine in MS, investigation of associations and any diet: or sex-specific influences in other populations is warranted.
Source: ConclusionAuthors’ abstract
Purpose
Choline and betaine may be neuroprotective; however, the role of choline and betaine obtained from food in multiple sclerosis (MS) onset in humans is unclear. We aimed to test associations between intake of choline and betaine from food and likelihood of a first clinical diagnosis of central nervous system demyelination (FCD).
Methods
We used data from the Ausimmune Study, a large, multi-centre case: control study conducted in four latitudinally diverse regions of Australia. Choline and betaine intakes were derived from food composition data sourced globally and dietary intake data collected using a self-administered, semiquantitative food frequency questionnaire. We used the alternate Mediterranean diet score (aMED) as a measure of diet quality. We applied logistic regression with full propensity score matching (264 cases, 474 controls) and stratified by sex (females: 205 cases/368 controls; males 59 cases/106 controls) to test associations between dietary choline and betaine intakes (per 50 mg/day) and likelihood of an FCD.
Models were adjusted for age, region, education, smoking history, history of infectious mononucleosis, deseasonalised serum 25-hydroxyvitamin D concentration, total energy intake, dietary misreporting and aMED, and bootstrapped (500 replicates).
Results
Independent of an overall healthy diet, higher choline intake (OR = 0.91; 95%CI 0.84 to 1.00; p = 0.05) and higher combined choline + betaine intake (OR = 0.92; 95%CI 0.86 to 0.99; p = 0.03) were significantly associated with lower likelihood of FCD in females only. We found no statistically significant associations in males (small sample).
Conclusion
Given the potential beneficial role of choline and betaine in MS, investigation of associations and any diet: or sex-specific influences in other populations is warranted.
Supplementary Information
The online version contains supplementary material available at 10.1007/s00394-026-03915-x.
Publication and source details
Original title: Higher dietary choline and betaine intakes are associated with lower likelihood of central nervous system demyelination in Australian women
Paul Bailey; Hajar Mazahery; Lucinda J. Black; Alison Daly; Yasmine Probst; Ingrid van der Mei; Eleanor Dunlop
European Journal of Nutrition · 2026
© The Author(s) 20262026https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.Deakin UniversityOpen Access funding enabled and organized by CAUL and its Member Institutions
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T00:02:45.200387+00:00
DOI: 10.1007/s00394-026-03915-x · PMC12906510